Yue Zhao
Beijing Tongren Hospital(CN)Shanghai Medical College of Fudan University(CN)Harbin Medical University(CN)Jinan University(CN)State Grid Corporation of China (China)(CN)Capital Medical University(CN)Fudan University(CN)National Health and Family Planning Commission(CN)Chinese PLA General Hospital(CN)Fudan University Shanghai Cancer Center(CN)Third Affiliated Hospital of Harbin Medical University(CN)Second Affiliated Hospital of Nanjing Medical University(CN)Beijing Chaoyang Emergency Medical Center(CN)Nanjing Medical University(CN)Nanjing University(CN)Vanderbilt University Medical Center(US)
Publications by Year
Research Areas
Radiomics and Machine Learning in Medical Imaging, MRI in cancer diagnosis, COVID-19 Clinical Research Studies, Hepatocellular Carcinoma Treatment and Prognosis, Hepatitis C virus research
Most-Cited Works
- → RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study(2021)4,256 cited
- → 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study(2023)883 cited
- → Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection(2015)514 cited
- → Loci and candidate gene identification for resistance to Sclerotinia sclerotiorum in soybean (Glycine max L. Merr.) via association and linkage maps(2015)136 cited
- → Simplified Hepatitis C Virus Genotyping by Heteroduplex Mobility Analysis(2000)86 cited
- → LP02 : C-surfer: grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease(2015)